Custom gene knockout in the industrial GRAS/QPS-qualified host strains (use-specific) Corynebacterium glutamicum.
We deliver verified knockout strains of C. glutamicum with standard QC documentation, enabling you to focus on downstream applications.
We combine established homologous recombination and CRISPR-based methods to generate precise gene deletions in this industrially important amino-acid producer.
We design knockout constructs based on your target gene sequence, selecting the most efficient editing strategy—either traditional homologous recombination or CRISPR-Cas9—to evaluate deletion success.
From vector construction to transformation and clone screening, our workflow is optimized for C. glutamicum to deliver knockout strains in a timely manner.
Each project begins with a consultation to define the optimal editing strategy based on your gene and strain background.
Knockout is confirmed by PCR and sequencing of the target locus; off-target checks are available upon request.
You receive verified clonal strains and full QC data, ready for downstream applications such as metabolic engineering or functional studies.
Each knockout project includes the following standard deliverables.
Project parameters are defined during consultation and recorded in the statement of work.
| Parameter | Typical project scope |
|---|---|
| Target gene | Scoped per project after consultation |
| Editing strategy | Homologous recombination or CRISPR-Cas9; strategy selected based on gene and strain. |
| Strain background | C. glutamicum ATCC 13032 or client-provided strain (subject to compatibility). |
| Number of clones screened | Typically 8–16 colonies screened; additional screening scoped per project. |
| Off-target analysis | In silico prediction and targeted amplicon sequencing of top off-target sites (scoped). |
| Antibiotic selection marker | Kanamycin or chloramphenicol resistance cassette; marker removal options available on request. |
Our streamlined process from target design to strain delivery.
We review your target gene sequence, strain background, and project goals to select the most suitable knockout strategy—homologous recombination or CRISPR-Cas9—and design the construct.
Knockout vectors are assembled with homologous arms or sgRNA/Cas9 components, verified by restriction digestion and sequencing before transformation.
The validated vector is introduced into C. glutamicum via electroporation or conjugation; candidate transformants are selected on antibiotic-containing plates and then screened for the intended edit.
Candidate clones are screened by colony PCR across the deletion junction, and positive clones are confirmed by Sanger sequencing to support precise gene knockout.
The validated knockout strain is cultured, quality-controlled, and provided as glycerol stocks or lyophilized pellets along with project documentation.
Knockout strains serve as key tools across multiple C. glutamicum research areas.
Block competing pathways to redirect carbon flux toward target amino acids or chemicals, improving production yields.
Investigate gene essentiality, decipher gene function, and construct defined mutant libraries for systems biology.
Develop robust production strains with targeted deletions evaluated for effects on substrate utilization, byproduct formation, and tolerance.
Common questions about our C. glutamicum knockout service.
We offer both traditional homologous recombination (using a suicide vector with homologous arms) and CRISPR-Cas9-mediated knockout. The choice depends on target gene characteristics and project timeline; our scientists will recommend the optimal approach during the consultation.
Knockout is confirmed by PCR amplification across the deleted region followed by Sanger sequencing of the amplicon. This assesses the deletion junction and checks for a detectable wild-type allele in the tested amplicon.
Yes, we can accept client-provided strains if they are transformable and compatible with our selection system. A preliminary strain test may be required to support successful transformation.
Turnaround time depends on the complexity of the knockout and the number of clones required. We will provide an estimated timeline during project scoping.
Get a customized quote for your Corynebacterium glutamicum Gene Knockout Service project. Our experts will respond within 24 hours.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.